Rheumatology Experts & Viewpoints

 

POLL

A new bill in Congress would send trained clinicians into doctors’ offices with independent data about the relative benefits, risks, and costs of drugs; some research suggests that such "academic detailing" reduces potential prescribing bias from the influence of drug company reps. What effect do you think such a program would have?
Would significantly reduce bias
Would somewhat reduce bias
Would not reduce bias
Uncertain
My prescribing decisions are not influenced by drug company representatives
Related Link: Senate press release
 
 
 

Featured Viewpoint

 
  • Update On Lupus: Treatment Reality Check In this update video blog on treating systemic lupus erythematosus, Stephen Paget, MD, highlights issues surrounding current clinical trials and present a personal approach to treatment.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.